Develops MS-based analytical methods and metabolic profiling to identify emerging drugs and impurities and evaluate toxicity. Work spans street-like synthesis, in vitro assays and alternative models, limited in vivo studies, and contaminant surveillance to inform clinical and forensic decisions.